In a groundbreaking advancement poised to reshape the landscape of drug discovery and chemical biology, researchers have unveiled innovative methodologies enabling the on-DNA C–H functionalization of electron-rich arenes to build DNA-encoded libraries (DELs) with unprecedented efficiency and diversity. This pioneering work, spearheaded by de Pedro Beato, Torkowski, Hartmann, and colleagues, introduces synthetic strategies that complement the existing DEL toolbox by addressing a long-standing challenge: achieving selective C–H bond activation directly on DNA-conjugated substrates without compromising the biomolecule’s integrity. The implications of this advancement resonate deeply with the pharmaceutical industry’s relentless pursuit of novel chemical entities that can accelerate hit identification and lead optimization.
DNA-encoded libraries, a transformative platform that marries combinatorial chemistry with high-throughput sequencing, rely heavily on the ability to perform diverse chemical reactions directly on DNA-tagged molecules. Historically, DEL construction has faced limitations because many synthetic transformations are incompatible with the sensitive DNA backbone and the aqueous conditions required for its stability. Specifically, the direct functionalization of C–H bonds on electron-rich arenes, a class of aromatic compounds with significant relevance in medicinal chemistry, has been largely inaccessible due to the risks of DNA degradation and lack of regioselectivity. The new methodology confronts these obstacles head-on by developing chemoselective reactions that preserve DNA integrity, enabling robust functionalization with exquisite control.
Central to this breakthrough is the strategic use of mild reaction conditions tailored to maintain the delicate balance between chemical reactivity and biocompatibility. The team leveraged transition metal catalysis under aqueous-friendly environments, optimizing catalysts and reaction parameters to engage electron-rich aromatic systems on DNA-conjugated substrates. This approach exploits the inherent electronic properties of arenes to direct C–H activation selectively, circumventing the need for pre-functionalized handles or harsh reagents. By fine-tuning the catalyst ligands and reaction milieu, the researchers achieved a remarkable degree of site-selectivity, enabling modifications at positions previously elusive in the context of DNA-encoded chemistry.
.adsslot_ogZFkUM9sB{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_ogZFkUM9sB{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_ogZFkUM9sB{width:320px !important;height:50px !important;}
}
ADVERTISEMENT
Mechanistically, the on-DNA C–H functionalization hinges on harnessing transient coordination between the metal catalyst and the aromatic ring, facilitating activation of otherwise inert C–H bonds. Electron-rich arenes provide nucleophilic sites amenable to such activation, and the method elegantly exploits this electronic bias to promote regioselective transformations. Additionally, the team demonstrated that reaction kinetics and catalyst design play crucial roles in minimizing off-target effects and DNA damage. The reactions proceed under aqueous buffered conditions at moderate temperatures, reflecting a meticulous balance between efficient catalysis and biological compatibility.
One of the major scientific hurdles overcome in this work is the mitigation of DNA degradation, a pervasive issue when deploying metal-catalyzed transformations in the presence of nucleic acids. The researchers embarked on an extensive screening of catalysts, additives, and reaction parameters to identify conditions that suppress DNA strand scission and crosslinking. Notably, the optimized protocol incorporates radical scavengers and buffering agents which stabilize the DNA duplex, ensuring that the functionalization does not compromise downstream amplification or sequencing, essential for DEL decoding. This careful orchestration exemplifies the interdisciplinary expertise required to innovate at the chemistry-biology interface.
The utility of the newly established C–H functionalization method was underscored by the construction of diverse small-molecule libraries directly on DNA strands. The platform affords facile introduction of various functional groups including alkyl, aryl, and heteroatom-containing moieties, expanding the chemical space accessible for biological screening. This chemical diversity, paired with the high-throughput sequencing capabilities inherent to DEL technology, dramatically enhances the potential to identify high-affinity ligands against challenging biological targets such as protein-protein interaction interfaces, allosteric sites, and enzymes with atypical active sites.
Beyond the immediate impact on DEL synthesis, this research offers fundamental insights into the compatibility of transition metal catalysis with biomolecules. The team’s findings could catalyze further exploration into DNA-compatible synthetic methods, potentially extending to other classes of C–H bonds and different nucleic acid conjugates. Such expansion would amplify the chemical versatility of DELs and open new avenues for creating multifunctional molecules with precisely tuned pharmacophores. Moreover, the modularity of the approach suggests adaptability to automated synthesis platforms, an essential feature for scaling DEL production in industrial settings.
The implications for drug discovery are profound. DELs generated by on-DNA C–H functionalization strategies can accelerate the identification of novel chemical probes and therapeutic candidates by enabling access to chemical motifs previously underrepresented in screening libraries. Through harnessing direct aromatic functionalization, researchers are empowered to explore fragment-like and lead-like compounds with improved physicochemical properties, potentially translating into better pharmacokinetics and bioavailability in clinical candidates. The approach also facilitates rapid structure-activity relationship (SAR) studies directly on DNA, streamlining lead optimization workflows.
This innovation also signifies a paradigm shift in the way chemists think about synthetic flexibility in DELs. While traditional DEL synthesis has often been restricted to reactions compatible with mild conditions and the presence of DNA tags, this advancement broadens the scope to include transformations traditionally thought incompatible with such delicate biomolecules. By demonstrating the feasibility of C–H activation on DNA-conjugated substrates, the work challenges preconceived boundaries and encourages the exploration of hitherto untapped chemistries for library diversification.
From a practical standpoint, the researchers employed rigorous validation protocols including next-generation sequencing to confirm the fidelity of DNA tags post-functionalization and high-resolution mass spectrometry to characterize the chemical modifications. These meticulous analyses ensure that the functionalized libraries retain their integrity throughout the screening pipeline, guaranteeing reliable identification of binding events. Furthermore, the team conducted comparative studies benchmarking their C–H functionalization method against established DNA-compatible transformations, highlighting enhanced efficiency and structural complexity in resultant libraries.
The report also discusses potential applications in addressing “undruggable” targets—those with shallow or dynamic binding pockets that have historically evaded traditional small molecule ligands. By enabling direct modification of electron-rich arenes on DNA, chemists can now incorporate unique structural features into DEL members, creating molecules with improved target engagement profiles. This is especially relevant for emerging therapeutic areas such as oncology, neurodegenerative diseases, and immunomodulation, where the chemical repertoire has needed expansion to tackle complex biological systems.
Another exciting prospect emanating from this work is the realm of fragment-based drug discovery coupled with DNA encoding. The controlled C–H functionalization technique allows for the iterative assembly of complex molecules from simple aromatic fragments directly on DNA, bridging the gap between fragment hits and lead compounds within a unified framework. This could significantly reduce the synthetic steps and time required to generate candidates with optimized bioactivity, enhancing the overall efficiency of early drug discovery stages.
The study’s success also owes much to interdisciplinary collaboration, drawing from organic synthesis, catalysis, molecular biology, and computational chemistry. By integrating insights from these diverse fields, the team crafted a sophisticated approach that integrates chemical innovation with molecular biology demands. Such synergy exemplifies the future of chemical biology, where traditional boundaries between disciplines dissolve to foster technology breakthroughs with broad-reaching implications.
In conclusion, this seminal contribution demonstrates that the limits of DNA-encoded library synthesis are no longer confined by the fragility of the encoding biomolecule. Through clever catalytic design and reaction optimization, the direct functionalization of C–H bonds in electron-rich arenes on DNA can be realized, substantially boosting the diversity, complexity, and utility of DELs in drug discovery. As the pharmaceutical community embraces these advances, the pace of identifying transformative therapeutics is set to accelerate, reflecting the power unleashed when synthetic organic chemistry and molecular biology converge.
Subject of Research: On-DNA C–H functionalization of electron-rich arenes to expand the chemical diversity of DNA-encoded libraries.
Article Title: On-DNA C–H functionalization of electron-rich arenes for DNA-encoded libraries.
Article References:
de Pedro Beato, E., Torkowski, L., Hartmann, P. et al. On-DNA C–H functionalization of electron-rich arenes for DNA-encoded libraries. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01844-6
Image Credits: AI Generated
Tags: C–H bond functionalizationchallenges in DNA-conjugated substratescombinatorial chemistry techniquesDNA-encoded librariesdrug discovery methodologieselectron-rich arenes in chemistryenhancing chemical diversity in DELshigh-throughput sequencing in drug developmentimproving hit identification in drug designpharmaceutical industry advancementsselective C–H bond activationsynthetic strategies for DELs
